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1. The structure of bone and the mechanisms for self-repair 
Bone is one of the most commonly transplanted tissues, with 2.2 million bone grafts 
performed annually worldwide (Tronci et al., 2013a). Surgeons face a diverse spectrum of 
clinical challenges in bone reconstruction, and this diversity reflects the variety of anatomic 
sites, defect sizes, mechanical stresses, and available soft tissue cover. Autologous bone 
grafting remains the gold standard for the reconstruction of skeletal defects (McMahon et al., 
2013), although drawbacks, including limited supply, bone graft loss/resorption, and donor 
site morbidity, impose a pressing demand for advanced biomaterial solutions. For these 
reasons, the World Health Organization (WHO) has confirmed the current decade as the 
‘Bone and Joint Decade’. 
To develop successful bone scaffolds, clinicians must adopt a multidisciplinary approach 
in order to understand and stimulate the natural bone regeneration process. In addition to an 
understanding of cell biology and genetics, this approach requires knowledge of bone 
structure and its hierarchical organisation, from the macro (centimetre) to the nano 
(extracellular matrix, ECM) scales (Figure 1). At the macroscopic structural level, bone 
consists of a dense shell of cortical bone that supports and protects. The interior porous 
cancellous bone optimises weight transfer and minimises friction at the articulating joints 
(McMahon et al., 2013). Cortical bone is composed of repeating osteon units, whereas the 
cancellous bone is made of an interconnecting framework of trabeculae with bone marrow-
filled free spaces. These trabeculae and osteon units are composed of collagen fibres. In the 
osteons, 20–30 concentric layers of fibres, called lamellae, are arranged at 45° surrounding the 
central canal, and they contain blood vessels and nerves. 
Moving from the macroscopic to the molecular level, bone is a composite material, 
consisting of cells embedded in the ECM. The ECM plays a key role in the localisation and 
presentation of biomolecular signals, which are vital for neo-tissue morphogenesis. 
Proteoglycans, glycosaminoglycans, and mineralised collagen are integrated in a 
supramolecular hydrogel. Collagen fibrils are arranged with a 67-nm periodicity and 40 nm 
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gaps where hydroxyapatite crystals are situated. The mineral phase is thought to dominate the 
stiffness of bone, which increases more than linearly with mineral content. The toughness of 
the material is thought to mainly arise from its hierarchical organisation, whereby the lowest 
hierarchical level contributes to the outstanding bone fracture resistance (Dunlop and Fratzl, 
2010). This unique hierarchical organi- sation enables bone to exhibit mechanical properties 
far superior to those of its single components. Thus, the repair and reconstruction of bone 
defects require innovative strategies that can closely mimic the complex tissue hierarchical 
organisation.  
 
Figure 1. Hierarchical organisation of bone over different length scales. B one tissue structure, function, and 
shape are regulated by the extracellular matrix (ECM), a supramolecular hydrogel network, in which cells are 
immersed. The ECM is mainly composed of collagen fibrils mineralised with hydroxylapatite crystals. Fibrils 
result from the assembly of collagen triple helices, which are based on left-handed polyproline chains at the 
molecular level. 
 
 
For bone regeneration, bone healing processes must also be given careful consideration. 
Bone has the capacity to repair itself, and this self-repair can be harnessed to repair small 
bone defects, heal non-unions, and lengthen short bones. Fracture healing is a complex 
regenerative process initiated in response to injury, in which bone can heal by primary or 
secondary mechanisms (Alman et al., 2011). In primary healing, new bone is laid down 
without any intermediate. This type of healing is rare in a complete bone fracture, except 
when the fracture is rigidly fixed through certain types of surgery. In the more common 
secondary mechanism of healing, immature and disorganised bone (i.e., callus) forms between 
the fragments. During the fracture repair process, cells progress through stages of 
differentiation reminiscent of those that cells progress through during normal foetal bone 
development. In the normal development of long bone, undifferentiated mesenchymal cells 
initially form a template for the bone, which then differentiates into chondrocytes. After this 
phase, blood vessels enter the cartilaginous template, and osteoblasts, which differentiate 
from perivascular and other cells surrounding the bone, form bone. The reparative process is 
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impaired in large, critical-sized bone defects (i.e., gaps beyond 2.5 times the bone radius) 
(Schroeder and Mosheiff, 2011), and osteoblastic differentiation is inhibited, with 
undifferentiated mesenchymal tissue remaining at the fracture site. Such defects can be caused 
by blunt or penetrating trauma, surgical treatment of tumours or necrosis caused by radiation, 
or various chemical substances. These defects represent a considerable surgical challenge, are 
associated with high socioeconomic costs, and highly influence patients’ quality of life, both 
private and professional (Woodruff et al., 2012). Despite huge progress being made toward 
the design of bone implants, the integration of all tissue properties and functions in a single 
biomaterial system remains a major research challenge. Researchers still need to develop 
reliable tools enabling them to systematically and temporally control the material structure 
and organisation, properties and functions, so that next-generation scaffolds can successfully 
ensure full clinical relevance. Fibrous assemblies in the form of nonwoven scaffolds have 
been repeatedly investigated over the last 20 years in relation to tissue regeneration. As the 
requirements of clinicians become more and more tissue specific, and synthetic biofunctional 
biomaterials are developed, nonwoven scaffold engineers must be able to respond with the 
capability to produce truly biomimetic architectures. 
 
 
2.    Fibre manufacture from biomaterials 
Biomaterials for bone regeneration should be biocompatible, biodegradable substances 
that support cell attachment, spread, proliferate (osteoconductive), and control cell 
differentiation into osteogenic lineages (Dawson et al., 2011; El-Gendy et al., 2013; Yang et 
al., 2003b). For a biomaterial to be suitable for manufacture into a nonwoven scaffold, it must 
be suitable for conversion into fibres, and the method of extrusion should not adversely affect 
biocompatibility or the properties of the material. A variety of natural and synthetic 
biomaterials can be converted into fibres, with different extrusion methods being applied 
depending on the composition of the biomaterial. These include, wet and dry solution 
spinning, melt spinning, and gel spinning. Materials extracted from a natural source, such as 
collagen, are attractive biomaterials, but the retention of the native structure after 
solubilisation and the precipitation of the regenerated product after spinning remain 
challenging. Synthetic biomaterials, notably those exhibiting thermoplastic behaviour, are 
often more straightforward to extrude due to their excellent mechanical properties, but such 
materials can lack suitable surface chemistry for cell attachment, and they might produce 
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undesirable degradation products in vivo. One issue can be the inflammatory response of the 
surrounding tissues while the polymer hydrolytically degrades (Agrawal and Ray, 2001; Cai 
et al., 2007). Hybrid materials containing both synthetic and natural materials, such as 
regenerated collagen or blends of two or more polymers, provide one means for balancing the 
required mechanical and chemical prop- erties. Additionally, the incorporation of materials 
such as hydroxyapatite tricalcium phosphate (Day et al., 2005; Mastrogiacomo et al., 2006) 
during spinning also enables the properties of the bulk product to be substantially modified 
according to specific clinical requirements. Both the biomaterial composition and the method 
of fibre extru- sion affect the bulk properties of the resulting nonwoven scaffold architecture. 
One scaf- fold parameter that has received considerable attention is the production of fibres 
of submicron diameter. Nanofibrous scaffolds have long been championed by the tissue 
engineering community with early work on electrospun polylactide nanofibre-based tissue 
engineering scaffolds indicating that human mesenchymal stem cells tended to proliferate 
more on nanofibre scaffolds than on microdiameter fibrous scaffolds (Shanmugasundaram et 
al., 2004). Since then, many reports have shown that nanofi- brous scaffolds support  cell  
growth for  tissue  regeneration  (Chung et  al.,  2011; Huang et al., 2011; Kumbar et al., 
2008). However, conflicting evidence also suggests that nanofibres are only preferential to 
microfibres when using synthetic biomaterials (Rnjak-Kovacina and Weiss, 2011). One of the 
challenges in designing three-dimensional scaffolds containing submicron fibres that pack 
closely together is facilitating adequate cell penetration into the full thickness of the fibrous 
assembly. The selection of an appropriate biomaterial from which to manufacture a 
nonwoven scaffold is, of course, a major consideration, and in bone regeneration, the 
evaluation of mate- rials has included regenerated collagen, gelatin (Venugopal et al., 2008), 
poly(lactic acid) (Kim et al., 2006), poly(lactic-co-glycolic acid) (Liao et al., 2008), silk 
fibroin (Kim et al., 2005), chitosan (Shin et al., 2005), and poly(ε-caprolactone) (Porter et al., 
2009). For brevity, further discussion in this chapter is restricted to collagen and 
poly(ε-caprolactone) nonwoven production. 
 
2.1    Collagen 
Collagen has been widely applied for the design of tissue-like matrices for repair (Hong 
et al., 2010) because of its natural occurrence in bone tissue. The collagen molecule is based 
on three left-handed polyproline chains, each of which contains the repeating unit Gly-X-Y, 
with X and Y being predominantly proline (Pro) and hydroxyproline (Hyp), respectively. The 
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three chains are staggered from one another by one amino acid residue and are twisted 
together to form a right-handed triple helix (300 nm in length, 1.5 nm in diameter). In vivo, 
triple helices can aggregate to form collagen fibrils, fibres, and fascicles, which are stabilised 
via intermolecular enzymatic crosslinking (Buehler, 2008; Grant et al., 2009). However, 
collagen properties are challenging to control in physio- logical conditions due to the fact that 
collagen’s unique hierarchical organisation and chemical composition in vivo can only be 
partially reproduced in vitro. As a result, regenerated collagen materials display 
non-controllable swelling and weak mechanical properties in physiological conditions. The 
limited solubility in organic solvents, high swelling in aqueous solution, and non-controllable 
batch-to-batch variation in chemical properties represent significant challenges to the use of 
collagen for the design of defined, water-stable nonwovens. To improve its stability, collagen 
has been widely crosslinked with N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide   
hydrochloride (EDC) (Olde Damink et  al., 1996), glutaraldehyde (GTA) (Olde  Damink et  
al., 1995b), and hexamethylene diisocyanate (HDI) (Olde Damink et al., 1995a). In the first 
case, zero-length covalent net-points are formed so that no harmful and potentially cytotoxic 
molecules are introduced (Haugh et al., 2011). Due to the minimal net-point length, however, 
crosslinking of adjacent collagen molecules is unlikely because the terminal amino functions 
are too far apart to be bridged, resulting in non-varied mechanical properties. In contrast to 
EDC, GTA and HDI involve the covalent incorporation of oligomeric segments between 
distant collagen molecules. The reaction of collagen with aldehydes or isocyanates in 
aqueous solution has been reported to result in a cascade of non-controllable side reactions 
and the formation of highly reactive and potentially toxic functional groups coupled to the 
polymer backbone (Zhang et al., 2011). To avoid such undesirable side reactions, collagen 
has been crosslinked with diimidoesters, such as dimethyl suberimidate, 
3,3’-dithiobispropionimidate, and acyl azide, resulting in stable materials in physiological 
conditions, although the extensibility of the material was reduced (Charulatha and Rajaram, 
2003). Dehydrothermal treatment or riboflavin-mediated photocrosslinking has also been 
applied as physical, benign crosslinking methods, although partial loss of native collagen 
structure and nonhomogeneous cross- linking was observed in these cases (Weadock et al., 
1995). Rather than direct covalent crosslinking, alternative approaches have recently focused 
on the formation of injectable ECM-mimicking gels via synthetic collagen blends (Hartwell 
et al., 2011), as well as the design of cell-populated matrices via derivatisation with 
cinnamate (Dong et al., 2005) or acrylate (Brinkman et al., 2003) moieties. In these methods, 
although the resulting mechanical properties may be enhanced, synthetic components, such as 
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polymers or co-monomers, are required to promote the formation of water-stable matrices, 
and the alteration of the protein backbone and biofunctionality may result. 
Reliable synthetic methods must therefore be applied in order to improve thermo- 
mechanical behaviour, without affecting biofunctionality (de Moraes et al., 2012), 
specifically biocompatibility and bioactivity. To address these challenges, collagen fibres can 
be chemically functionalised (Tronci et al., 2013c), so that a covalent net- work is established 
at the molecular level (Tronci et al., 2013b); in this way, temporal stability of  both fibres and 
mesh architecture  may  be  ensured in  physiological conditions. 
Collagen fibrillogenesis can be induced in vitro by exposing monomeric collagen 
solutions to physiological conditions, resulting in viscoelastic gels at the macroscopic level 
(Lai et al., 2011). The design of collagen mimetic peptides has also been proposed as an 
alternative strategy for recapitulating the multiscale organisation of natural collagen (O’Leary 
et al., 2011). However, despite the formation of hierarchical triple helix assemblies, the 
resultant thermal and mechanical stability is still not adequate for biomaterial applications, so 
that chemical functionalisation of side- or end-groups is crucial. 
The functionalisation of collagen requires careful consideration, because the hier- 
archical organisation of collagen imposes constraints in terms of protein solubility, the 
occurrence of functional groups available for chemical functionalisation, and material 
biofunctionality. As improved synthetic methods are developed, functionalised collagen with 
preserved protein conformation and full biocompatibility will become available, enabling the 
manufacture of better performing biomimetic, nonwoven architectures. There have been two 
distinct approaches to collagen fibre formation. The tissue engineering community has 
mainly focused on electrospinning, whereas industries producing artificial hair and textile 
fibres have exploited conventional wet-spinning approaches. 
Electrospinning of collagen involves the extrusion of a positively charged polymer 
solution with the resulting fibres being collected as a nonwoven web on a grounded or 
negatively charged collector. The majority of studies involving the production of collagen 
fibres without a second carrier polymer involve the use of 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFIP) as the solvent. The popularity of HFIP is based on the dual role it plays in collagen 
solubilisation – two trifluoromethyl groups serve to break hydrophobic interactions, and the 
mildly acidic secondary alcohol hydroxyl group assists in breaking the hydrogen bonds 
(Dong et al., 2009). However, cytotoxicity and the destructive effect on the structure of 
functionalised collagen have inspired a search for more benign sol- vents. Both collagen and 
gelatine have been successfully electrospun in a mixture of phosphate buffer saline/ethanol to 
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produce fibres with average diameters ranging from 0.21 to 0.54 mm, depending upon the 
salt concentration (Zha et al., 2012). Note that vacuum drying is still normally required to 
remove the solvent after spinning. 
The traditional wet spinning of collagen fibres has two major advantages. First, fibres 
can be produced with larger diameters, if required, and the fibre orientation and architecture 
of the nonwoven scaffold can be manipulated independent of the spinning process. Second, 
the stretching and drying of the extruded filaments are easier to control. In its simplest form, 
wet spinning involves dissolving the polymer in an appropriate solvent and then extruding the 
polymer solution via a spinneret into a coagulation bath containing a non-solvent. Collagen 
has been solubilised in acidic environments and wet-spun into coagulation baths containing 
different ethanol/ acetone mixtures, resulting in fibres with diameters ranging from 89 to 140 
mm and tenacities of between 8.5 and 8.3 cN/tex (Meyer et al., 2010). Such fibre dimensions 
are larger than those typically targeted in the manufacture of tissue engineering scaffolds, but 
smaller diameters may be obtained through the appropriate control of manufacturing 
conditions. Owing to the excellent control of fibre dimensions and the high delivery speeds 
that are possible during production, wet spinning is an attractive route for the production of 
functionalised collagen fibres. Melt or thermo- plastic spinning of collagen to produce fibres 
has also been reported, but the high temperatures required cause denaturing and are likely to 
disrupt functionalisation, so resulting materials are unlikely to be appropriate for tissue 
engineering applications (Meyer et al., 2010). 
The structural and mechanical properties of chemically functionalised collagen fibres are 
of paramount importance in terms of the biocompatibility and mechanical performance for 
bone tissue engineering. Two major challenges in the production of collagen using synthetic 
methods are the ability to control material stability in physiological conditions and the 
preservation of the native protein conformation. Preservation of the triple helix structure is 
crucial for ensuring enzymatic implant degradability. Here, intact triple helices are required 
to promote effective degradation of fibrillar collagen (Gaudet and Shreiber, 2012). If the 
tertiary structure is significantly altered, then collagenase degradation rates could also be 
affected, in turn influencing material biodegradability, as well as the extent to which cells 
remodel the scaffold. Attenuated total reflectance and Fourier transform infrared 
spectroscopy (ATR-FTIR) is a useful analytical technique for elucidating the protein 
molecular conformation in collagen scaffolds manufactured using a synthetic route. Collagen 
displays distinct amide bands via FTIR, which characterise its triple helix structure. These are 
(i) amide A and B bands at 3300 and 3087 cm
-1
, respectively, which are mainly associated 
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with the stretching vibrations of N–H groups; (ii) amide I and II bands, at 1650 and 1550 
cm
-1, resulting from the stretching vibrations of peptide C═O  groups  as  well  as  from  N–H  
bending  and  C–N  stretching  vibrations, respectively; (iii) an amide III band centered at 
1240 cm
-1
, assigned to the C–N stretching and N–H bending vibrations from amide linkages, 
as well as wagging vibrations of CH2 groups in the glycine backbone and proline side chains. 
Each of the previously mentioned amide bands should be exhibited in the FTIR spectra of 
functionalised collagen, whereby no detectable band shift will be displayed compared to the 
spectrum of native type I collagen (Figure 1). Other than qualitative findings on unchanged 
band positions, the FTIR absorption ratio of amide III to the 1450 cm
-1
 band (AIII/A1450) is 
usually determined in order to quantify the degree of triple helix preservation. In such a case, 
an amide ratio close to unity is associated with the preserved integrity of the triple helices (He 
et al., 2011) following functionalisation of native collagen (Tronci et al., 2013b). 
Other valuable analytical techniques for elucidating protein backbone conformation are 
circular dichroism (CD) and sodium dodecyl sulphate-polyacrylamide gel electrophoresis. 
CD is based on the fact that single collagen polyproline chains are stabilised into a triple helix 
structure via hydrogen bonds oriented perpendicularly to the triple helix axis, resulting in an 
optically active protein (Djabourov, 1988). This molecular feature is exploited by CD 
spectroscopy to investigate any alteration in protein conformation following either chemical 
functionalisation or fibre formation. Resulting collagen-based materials are dissolved in 
dilute acidic conditions and excited with plane-polarised light. Plane-polarised light can be 
viewed as being made up of two circularly polarised components of equal magnitude, one 
rotating counter- clockwise (left-handed, L) and the other clockwise (right-handed, R). CD 
refers to the differential absorption of these two components. If, after passage through the 
sample being examined, the L and R components are not absorbed or are absorbed to equal 
extents, the recombination of L and R would regenerate radiation polarised in the original 
plane. However, if L and R are absorbed to different extents, the resulting radiation would be 
said to possess elliptical polarisation, resulting in a CD signal (Kelly et al., 2005). One of the 
most significant advances that has been made in relation to scaffold performance and which 
will aid future work on the development of  functionalised  collagen  scaffolds  is  the  ability  
to  monitor  scaffolds  in  vivo (Cunha-Reis et al., 2013). 
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2.2    Poly(ε-caprolactone) 
Poly(ε-caprolactone) (PCL) is a biocompatible and bioresorbable semicrystalline 
aliphatic polyester that has been extensively reported in connection with medical applications 
including bone repair and regeneration. PCL has a degradation time between 2 and 4 years; 
however, the degradation time can be greatly altered by blending it with another polymer 
such as collagen. Owing to its biodegradability and exceptional mechanical properties, PCL 
fibre has been studied extensively in relation to bone engineering (Porter et al., 2009). Its 
popularity also results from its relatively low cost, ease of processing, and compatibility with 
both melt spinning, wet spinning, and electrospinning. The major disadvantage of PCL as a 
biomaterial is its lack of biofunctionality, although this can be compensated for, to some 
extent, by blending it with other biofunctional materials.  
The solvent electrospinning of PCL is well documented, with a large number of studies 
reporting PCL fibre spinning using the chloroform:methanol solvent system. By adjusting the 
ratio of chloroform to methanol, applied voltage, and tip to collector distance, electrospun 
webs with an average fibre diameter ranging from 2.3 to 10.8 mm can be obtained (Pham et 
al., 2006). Submicron PCL fibres can also be successfully spun using a solvent mixture of 
chloroform: N,N-dimethylformamide (Pham et al., 2006), and there is potential to produce 
webs in which both PCL nanofibres and micro- fibres are present, using the same equipment, 
although producing fibre diameters that are considerably larger than 10 mm remains a 
limiting factor. Melt electrospinning uses a similar set-up, but, because the polymer is 
extruded in a molten state, a heating element is required. In this process, the upper limit of the 
average fibre diameter that can be produced increases between 6 and 30 mm (Detta et al., 
2010). The high temperatures that are required during melt extrusion processes means that 
collagen and other biofunctional materials cannot be easily incorporated in the manufacture 
of fibres without the risk of degradation, however. Although melt spinning using operating 
temperatures of 85–90 °C is not appropriate for the production of PCL/collagen blends, 
biofunctional materials can be incorporated post-spinning in the form of coatings on the fibre 
surfaces. Traditional melt spinning (as opposed to melt electrospinning) enables the 
production of large quantities of fibre (Charuchinda et al., 2003) and the ability to produce 
either continuous filament or staple fibre. This provides greater versatility in the available 
nonwoven production routes and therefore the types of scaffold architecture and physical 
properties that can be manufactured. 
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Wet-spun PCL fibres can be extruded from polymer solution containing acetone and then 
spun directly into a methanol coagulation bath. As-spun PCL fibres have been reported with a 
diameter of 150 mm, reduced to 67 mm by cold drawing using an extension of 500% 
(Williamson et al., 2006). A major benefit of wet spinning, as opposed to the melt-spinning 
route, is the potential to produce mixed polymer fibres that incorporate the mechanical 
properties of PCL with the biofunctionality of a material such as collagen. However, 
appropriate co-solvents are required to facilitate this. The majority of studies have reported 
the use of HFIP as a solvent system for electrospinning blends of collagen and PCL. This is 
less than ideal because of the cytotoxic nature of any residual HFIP present in the as-spun 
fibres. Some alternative approaches have been developed, including those reported by 
Chakrapani et al. (2012) who used acetic acid as a solvent system for PCL and collagen 
mixtures. 
To improve the osteoconductivity and mechanical properties of scaffolds for bone 
engineering and to create a pH buffer against the acidic degradation of synthetic polymer 
matrices, researchers have investigated the incorporation of HA particles (Puppi et al., 2011). 
Ji et al. (2012) reported that nano-HA platelets significantly improved the mechanical 
properties, including the strength, strain, and toughness of electrospun collagen fibres. Puppi 
et al. (2011) wet-spun PCL fibres containing HA using acetone as a solvent and ethanol as a 
nonsolvent, and they produced fibres with diameters in the range of 100–250 mm. 
 
 
3.    Design and assembly of scaffold architectures 
In scaffold-guided tissue regeneration, three-dimensional scaffolds serve as temporary 
tissue substitutes that promote tissue regeneration at the defect site (Langer and Vacanti, 
1993). Scaffold design has to take into account the macroscopic properties of the material 
(e.g., degradability, porosity, and mechanical properties), processability, and the interaction 
with cells. Suitable porosity and pore interconnectivity are necessary to promote cell 
migration and differentiation, including within the interior of the scaffold; diffusion of 
oxygen and nutrient to cells (Botchwey et al., 2003); and removal of waste products from the 
scaffold. The same structure must also have mechanical properties that enable sharing of the 
physiological load, if functional neo-tissue is to develop. 
In a clinical setting, a nonwoven scaffold can be used alone or in combination with other 
materials, growth factors, and/or cells. If the scaffold is to be used alone, it must be designed 
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to act as a supporting structure that recruits stem/stromal cells from sur- rounding tissues (Shi 
et al., 2013; Zhang et al., 2008). In other instances, the scaffold can be designed and used as a 
carrier vehicle for bioactive growth factors in order to enhance osteoinduction, 
chondroinduction, and angiogenesis that are crucial for bone and osteochondral-tissue 
engineering (Green et al., 2004; Yang et al., 2004). Nonwoven scaffolds can also be used in 
combination with stem/stromal cells that can be directly delivered into the bone defect area to 
provide both osteogenesis and support elements for bone tissue engineering (Udehiya et al., 
2013; Yang et al., 2001). Scaffolds may be bioactive and contain autogenic and/or allogenic 
stem/stromal cells that can be directly delivered into the bone defect area to provide 
osteogenesis, osteoinductive, and osteoconductive elements for bone tissue engineering 
(Yang et al., 2003a,b, 2004). It is therefore important that the required function of the 
nonwoven scaffold and the selection of materials are carefully considered during the design 
and development process. 
Generally, nonwoven fabrics are highly porous, low-density fibrous assemblies of 
typically less than 0.40 g/cm
3
. The internal pore structure is highly interconnected, and there 
is a relatively wide pore size distribution that can be manipulated during nonwoven fabric 
manufacturing. The majority of fibres in nonwoven structures are arranged in a planar, x–y 
orientation, with only a limited number of processes, notably air-laid, vertically lapped, 
carded webs, with needling and hydroentangling capable of producing a degree of fibre 
orientation through-thickness. The fibre orientation distribution, which can be manipulated 
during production of the nonwoven scaffold, strongly influences the isotropy of fabric 
properties including directional mechanical properties and fluid transport. 
Different nonwoven architectures can be produced in the form of a scaffold depending 
upon the selection of manufacturing route. Nonwoven manufacture typically involves at least 
two sequential steps: web formation and bonding. Both dry-laid (e.g., carded, carded and 
lapped, air-laid) and wet-laid web formation processes utilise staple fibres that are cut to a 
predetermined length prior to nonwoven fabric manufacture. In contrast, spun-melt (e.g., 
spun-bond, melt-blown) and other direct filament deposition techniques, such as electrospun 
and force-spun web formation techniques, rely on the direct collection of continuous 
filaments in the form of a web. Depending on the polymer composition of the fibres in the 
web, one or more bonding techniques may be applied: mechanical (needling, 
hydroentangling, stitch-bonding), thermal bonding, or chemical bonding. Mechanical 
bonding relies on increasing fibre entanglement and frictional resistance within the web to 
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increase resistance to slippage, and therefore, fibre length, fibre diameter, breaking 
elongation, flexural rigidity, fibre mobility, and fibre–fibre friction are influential parameters. 
In dry-laid web formation, the carding of fibres to produce a web involves their 
progressive disentanglement as they are carried on rollers clothed in wire teeth, which 
involves fibre–metal and fibre–fibre friction. The low melting point of some biomaterials 
such as PCL (e.g., 60 °C) can therefore give rise to unwanted fusing of fibres during the 
carding as a result of frictional heating. Another challenge is the potential for excessive fibre 
breakage in biomaterial fibres that have low breaking extensions of less than 5%. Short-cut 
(<15 mm length) biomaterial fibres can also be air-laid to form webs, minimising the 
potential for fibre breakage during web formation, but mechanical bonding normally results 
in relatively weak scaffolds. An advantage of wet-laid processes is the high weight 
uniformity that can be achieved in the web; how- ever, the process requires suspension of 
short cut fibres in a liquid medium, which can be unsuitable for biomaterials that have poor 
aqueous stability. 
Thermal bonding of synthetic thermoplastic biomaterials such as PCL is also feasible. 
Practically, fibres with a concentric core-sheath bicomponent structure are preferred in order 
to minimise thermal shrinkage during heating and to maximise fabric strength while 
preserving the required internal fabric structure. Owing to biocompatibility issues, chemical 
bonding, in which an adhesive is applied to the web to prevent fibre slippage, is not normally 
considered appropriate for tissue scaffold manufacture, unless the binder is, in itself, a 
biomaterial suitable for invasive use. 
The production of nonwoven scaffolds with reproducible architectural features is 
challenging and remains an important issue with respect to quality control. In mechanically 
bonded tissue scaffolds, methods of controlling certain features of the internal architecture, 
such as pore structure, have been attempted by utilising templates (Durham et al., 2012). An 
example of a highly porous nonwoven architecture made by thermally bonding a carded web 
of bicomponent poly(lactic acid) (PLA) fibres around a removable spacer template to tune the 
internal pore structure is shown in Figure 2. Such modifications to existing nonwoven 
processes highlight the potential for manipulating scaffold structures in a reproducible 
manner during their production. 
In relation to biomimetic scaffolds, a major advantage of nonwovens is their highly 
interconnected pore structure and the scope that is available to control pore size distribution 
during manufacturing. The production of scaffolds with appropriate pore sizes is fundamental 
for their functionality. The minimum pore size for bone engineering is approximately 100 
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nm, due to cell size, migration requirements, and nutrient transport (Hutmacher et al., 2007). 
Mean pore sizes in electrospun webs are normally substantially lower than 100 nm, which 
means initial cell penetration into a thick, three-dimensional scaffold can be impeded. 
Increasing the fibre diameter is one approach to making larger pores, but this is not always 
practicable, depending on the biomaterial and spinning conditions. Other methods for 
increasing pore size involve combining electrospun polymers with sacrificial material, such 
as a porogen, that can be subsequently removed (Nam et al., 2007; Phipps et al., 2011). 
Force-spinning, which relies on using centrifugal forces instead of electrical charge to stretch 
the polymer jet (McEachin and Lozano, 2012), is an interesting candidate for scaffold 
production because the submicron diameter fibres that are deposited on the collector are less 
densely packed than they are in electrospinning.   
 
Figure 2. Cross section of a nonwoven scaffold 
produced by carding and through-air thermal bonding 
(100% core-sheath PLA staple fibre). The cavities 
correspond to regions where solid metallic spacer 
elements inserted prior to thermal bonding have been 
removed. 
 
 
 
 
 
 
 
 
 
 
Given that physiological tissue, including bone, is heterogeneous in structure, the ability 
to manufacture templated features in electrospun webs that biomimic the native structure is of 
interest to tissue engineers. Templating techniques have included use of an electronic circuit 
chip as a collector, which enabled the production of features on the order of several hundred 
microns (Wu et al., 2010). The majority of other approaches have used patterns in the range 
of millimetres. Producing well-defined features at the micron level may be hampered by 
electrical charge jumping across small nonconductive areas, however. Vaquette and Cooper-
White (2011) investigated ‘round’ collectors with a 1-mm diameter disc in the centre of the 
hole, a ‘star’ collector, and a ‘ladder’ collector that produced a variety of different scaffold 
architectures. In the manufacture of PCL scaffolds, a solvent system of 
chloroform/dimethylformamide or cholorform/methanol has been a route of choice, due to 
the conductivity of the solution, although the templating of other synthetic polymers such as 
poly(D,L-lactide- co-glycolide) has also been reported (Zhou et al., 2010). 
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A disadvantage of many templating techniques is that the structures remain relatively 
two-dimensional and do not truly biomimic the three-dimensional nature of physiological 
tissue such as bone. Various methods to produce multilayered structures have been explored, 
including stacking templated electrospun webs and fusing them using a hot pressing process 
(Dou et al., 2011). Collagen glue has also been used as an adhesive between stacked layers of 
scaffold (McCullen et al., 2010). Although such scaffolds are three-dimensional in terms of 
macroscopic thickness, the fibres remain orientated in the x–y directions and the pore 
structure reflects this. When multiple layers of web are stacked directly on top of each other, 
a reduction in the overall pore size can result, which is undesirable. 
Three-dimensional collectors can be used to collect electrospun fibres in architectures 
similar to that of a cotton ball. Blakeney et al. (2011) reported the application of a spherical 
foam dish with stainless steel probes radiating from its centre. This collector was used to 
deposit PCL fibres and produced a low-density, three-dimensional structure. Fibre diameters 
of    500 nm and pore sizes between 2 and 5 mm were obtained. Despite the original design of 
this collector, the pore size remained far below the suggested minimum pore size required for 
bone engineering of 100 nm. 
Direct-write electrospinning is also emerging as a means for introducing biomimetic 
features. The original direct-write technology allowed structures to be built directly, without 
the use of masks enabling the rapid prototyping of complex architectures (Chrisey, 2000). 
Combining the technology with electrospinning facilitates the production of complex fibrous 
architectures by additive manufacture. Both solution and melt electrospinning have been 
demonstrated to be compatible with direct writing. To enable direct writing, the 
electrospinning process is modified so that the fibres can be collected while the fibre 
deposition path is still straight. At the point of fibre contact with the collector, the majority of 
the solvent should either have been removed or the melt solidified, so that the fibres retain 
their incoming morphology. To enable the direct writing in this way, a fast moving lateral 
collector platform is required. Polymer melts can be drawn over a larger distance while 
remaining on a straight trajectory, as compared to their solution-spun counterparts. This 
allows the tip-to-collector distance to be greater, resulting in a longer time period for the 
molten polymer to solidify. In order to be able to write with a continuous line, the 
translational speed of the collector must match the jet speed at impact (up to 1 m/min in some 
instances). Consideration must also be given to the turning speed/dwell time during the 
writing of complex patterns and incorporated into the original programmed design. These 
patterned webs can be repeatedly manufactured on top of each other to produce 3D structures 
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with up to 1 cm thickness (Brown et al., 2012). To date, PCL has been frequently used 
because of its wide range of processing temperatures, allowing the production of fibres with a 
range of diameters between 19 and 28 mm (Brown et al., 2012). The resulting architectures 
are often geometric in design and made of multiple layers of large diameter fibres. 
Solution-based electrospun direct writing requires a similar set-up, but because of the 
time required for the solvent to be flashed off, a larger tip-to-collector distance is required. 
The set-up used by Lee et al. (2012) comprised a dielectric thin plate that was capable of 
lateral movement independent of the sharp-pin ground electrode. Nanofibres were collected 
as dense depositions in a defined area (the pin electrode), and writing was accomplished by 
movement of the collector surface. To add stability and three-dimensionality, multiple layers 
of nanofibres must be written on top of each other. Various patterns, such as lines, points, 
lattices, and grids, can be produced. Polymer selection is limited to those that can be spun 
successfully in volatile solvents such as chloroform, ensuring that the majority of the solvent 
is evaporated prior to the fibre depositing upon the collector. Although greater control of 
fibre deposition is achieved, the architectures are still relatively 2D in construction. 
Electrospinning into a liquid coagulating bath is a combination of electrospinning and 
conventional wet spinning. Wet electrospinning has received considerable attention due to its 
potential for decreasing fibre packing density and increasing the pore size in scaffolds. By 
using a solvent with a relatively low surface tension, fibres do not float on the surface and can 
disperse in the solvent, allowing architectures with a more pronounced three-dimensional 
structure to be formed (Yokoyama et al., 2009). Further increases in pore size can be obtained 
by incorporating porogens such as sodium chloride into the spinning bath (Gang et al., 2012). 
Synthetic polymers such as  poly(glycolic acid)  have  been  spun  in  solutions  of  
1,1,1,3,3,3-hexafluoro-2-propanol and collected in a bath of tertiary-butyl alcohol. The 
resulting architectures contained fibres with diameters ranging from 200 to 1400 nm. PCL 
has been spun into ethanol, which prevented the electrospun fibres from packing densely on 
top of each other (Yang et al., 2012). To prevent the architecture from collapsing when the 
solvent is removed, freeze-drying is required after spinning. 
The versatility of electrospinning as a technique for bone scaffold production is 
considerable, particularly when it is combined with techniques that enable better control of 
the fibrous architecture. Unfortunately, although a great variety of structural features can be 
introduced, the results cannot be described as truly biomimetic. Alternative nonwoven 
technologies are likely to be required to overcome some of the inherent limitations of 
electrospinning, and there is substantial scope given the range of processes that are already 
16 
 
commercially available. The challenge remains to engineer improved electrospun 3D 
architectures with both pore sizes and mechanical properties that are properly matched to 
clinical needs. 
 
 
 
4. Considerations for surgical implantation of nonwoven scaffolds 
To meet the specific clinical requirement, the researcher must consider many factors 
when designing and fabricating nonwoven scaffolds. The general requirements of 
biomaterials and scaffold architectures have already been discussed; however, these may 
need to be tailored, depending on the requirements of the specific bone defect. Common 
surgical situations that would be suitable for reconstruction using a nonwoven scaffold are 
listed in Table 1. Depending on the defect type, nonwoven scaffolds can be applied to the 
defect site in different ways. For a fracture model, the nonwoven scaffold may be used as a 
membrane/bandage to cover the fracture and/or bone defect area, whereas, for large defect 
sites, the nonwoven scaffold may be used as filler/ gauze, as shown in Figure 3. It is 
important to identify the intended use of nonwoven scaffolds and to incorporate appropriate 
features during the scaffold development phase. The final scaffold structure must be user-
friendly and should be sterile and supplied in a range of different sizes. It must also be ready 
to use and easy to handle by the surgeon. 
 
Table 1. Common surgical situations suitable for reconstruction using a nonwoven scaffold. 
 
 
 
Bone defect type 
Examples of surgical 
situations 
 
 
Reference 
 
Fracture nonunion: 
small bone defect 
after surgical 
procedure 
Segmental bone 
defect 
 
Flat bone 
 
Removal of benign 
tumour: unicameral bone 
cysts, periapical cyst, or 
tumour resection. 
Due to trauma or surgery 
 
 
Calvaria defect 
 
Khira and Badawy (2013), Di 
Stefano et al. (2012), and Gentile 
et al. (2013) 
 
Liu et al. (2013a), Gruber et al. 
(2013), Horner et al. (2010), and 
Udehiya et al. (2013) 
Liu et al. (2013b), Pelegrine et al. 
(2013), and Cooper et al. (2010) 
 
 
Consideration must also be given to the method of fixing the scaffold in the defect site. 
Not all nonwoven scaffolds require additional fixation because they can be pushed into place 
to fill the defect area. Push-fit nonwovens scaffolds must have sufficient recovery 
post-implantation to be able to mould to the contours of the defect site, thereby remaining in 
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situ. Biological glue or surgical adhesives may be helpful for keeping the scaffold in place 
(Kukleta et al., 2012). In a flat bone defect such as the calvaria defect, nonwoven scaffolds 
have the advantage of being able to be cut to the shape of the defect (Figure 4a). A 
well-fitting scaffold may not need any fixation, however, fixing may be needed if the bone 
defect is large. In such as case, a temporary protective layer/tissue flap may be required to 
cover the defect area before new bone is formed. Similarly, for nonunion fractures, the 
nonwoven scaffold may be kept in place by the surrounding tissues or with biological glue or 
surgical adhesives. In the case of spinal fusion, the nonwoven scaffold may be used as 
filler/ gauze and/ or strips to fill the defect area (Figure 4b), kept in place by the surrounding 
tissues. 
 
Figure 3. Possible use of nonwoven scaffolds for fracture repair/ bone tissue regeneration (in combination 
with/without cells and/or growth factors). (a) Fracture model: the nonwoven scaffold may be used as 
membrane/bandage to cover the fracture and/or bone defect area; (b) bone defect model: the nonwoven scaffold 
may be used as filler/gauze to fill the bone defect area. 
 
 
 
Figure 4. Possible application of nonwoven scaffolds in non-weight-bearing areas (in combination 
with/ without cells and/or growth factors). (a) Calvarial defect model: the nonwoven scaffold may be used as 
membrane/ gauze to fill the bone defect area; (b) spinal fusion model: the nonwoven scaffold may be used as 
filler/ gauze/ strips to fill areas that are required for spinal fusion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
+ 
Growth factors and/or cells 
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5. Future trends 
For nonwoven scaffolds to meet clinical requirements for bone repair and regeneration, they must be 
able to successfully biomimic aspects of the native tissue, and they must be sufficiently robust for 
surgical use. Furthermore, they need to be environmentally stable, reproducible in structure, and 
economically produced from appropriate biomaterials. Meeting these requirements using existing 
manufacturing techniques, such as electrospinning, is challenging, but the technology is rapidly 
evolving, and other multistage nonwoven manufacturing methods have yet to be fully explored as 
alternative production routes for bone scaffolds. Developments in biomaterial science are still 
required in order to provide fibre-forming materials that are compatible with large scale manufacture 
while satisfying all performance requirements. Biomaterials such as those based upon functionalised 
collagen have significant potential for the engineering of nonwoven scaffolds that address both 
biological and mechanical property requirements. The role of clinicians in guiding tissue scaffold 
design will continue to be fundamental to the development of functional scaffolds that meet individual 
patient needs. Better matching of scaffold properties to individual needs is essential if clinical 
outcomes are to improve, and this can increase the demand for the customisation of nonwoven 
scaffolds during manufacture and at the bedside. These developments have the potential to make a 
major impact on current scaffold manufacturing procedures, as well as the development of the 
regulatory framework. 
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